Helena Naly Miguens Rocha

Helena Naly Miguens Rocha

Auto-generated profile, based on publicly available information

Helena Naly Miguens Rocha

Fluminense Federal University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2016 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
TBThales C. Barbosa
Thales C. Barbosa
LVLauro C. Vianna
Lauro C. Vianna
IFIgor A. Fernandes
Igor A. Fernandes
EPEliza Prodel
Eliza Prodel
HRHelena N. M. Rocha
Helena N. M. Rocha
ANAntonio C. L. Nobrega
Antonio C. L. Nobrega

26 December 2018 in The Journal of Physiology
Verified
Journal Article
Open access
PDF file
JMJoão D. Mattos
João D. Mattos
MCMonique O. Campos
Monique O. Campos
MRMarcos P. Rocha
Marcos P. Rocha
DMDaniel E. Mansur
Daniel E. Mansur
HRHelena N. M. Rocha
Helena N. M. Rocha
IFIgor A. Fernandes
Igor A. Fernandes
Key points: It is unknown whether excessive reactive oxygen species (ROS) production drives the isocapnic hyperoxia (IH)‐induced decline in human cerebral blood flow (CBF) via reduced nitric oxide (NO) bioavailability and leads to disruption of the blood–brain barrier (BBB) or neural‐parenchymal damage. Cerebral metabolic rate for oxygen (CMR) and transcerebral exchanges of NO end‐products, oxidants, antioxidants and neural‐parenchymal damage markers were simultaneously quantified under IH with intravenous saline and ascorbic acid infusion. CBF and were reduced during IH, responses that were followed by increased oxidative stress and reduced NO bioavailability when saline was infused. No indication of neural‐parenchymal damage or disruption of the BBB was observed during IH. Antioxidant defences were increased during ascorbic acid infusion, while CBF, , oxidant and NO bioavailability markers remained unchanged. ROS play a role in the regulation of CBF and metabolism during IH without evidence of BBB disruption or neural‐parenchymal damage. To test the hypothesis that isocapnic hyperoxia (IH) affects cerebral blood flow (CBF) and metabolism through exaggerated reactive oxygen species (ROS) production, reduced nitric oxide (NO) bioavailability, disturbances in the blood–brain barrier (BBB) and neural‐parenchymal homeostasis, 10 men (24 ± 1 years) were exposed to a 10 min IH trial (100% O2) while receiving intravenous saline and ascorbic acid (AA, 3 g) infusion. Internal carotid artery blood flow (ICABF), vertebral artery blood flow (VABF) and total CBF (tCBF, Doppler ultrasound) were determined. Arterial and right internal jugular venous blood was sampled to quantify the cerebral metabolic rate of oxygen (CMR), transcerebral exchanges (TCE) of NO end‐products (plasma nitrite), antioxidants (AA and AA plus dehydroascorbic acid (AA+DA)) and oxidant biomarkers (thiobarbituric acid‐reactive substances (TBARS) and 8‐isoprostane), and an index of BBB disruption and neuronal‐parenchymal damage (neuron‐specific enolase; NSE). IH reduced ICABF, tCBF and , while VABF remained unchanged. Arterial 8‐isoprostane and nitrite TCE increased, indicating that CBF decline was related to ROS production and reduced NO bioavailability. AA, AA+DA and NSE TCE did not change during IH. AA infusion did not change the resting haemodynamic and metabolic parameters but raised antioxidant defences, as indicated by increased AA/AA+DA concentrations. Negative AA+DA TCE, unchanged nitrite, reductions in arterial and venous 8‐isoprostane, and TBARS TCE indicated that AA infusion effectively inhibited ROS production and preserved NO bioavailability. Similarly, AA infusion prevented IH‐induced decline in regional and total CBF and re‐established . These findings indicate that ROS play a role in CBF regulation and metabolism during IH without evidence of BBB disruption or neural‐parenchymal damage.

28 February 2018 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
IFIgor A. Fernandes
Igor A. Fernandes
MRMarcos P. Rocha
Marcos P. Rocha
MCMonique O. Campos
Monique O. Campos
JMJoão D. Mattos
João D. Mattos
DMDaniel E. Mansur
Daniel E. Mansur
ANAntonio C. L. Nóbrega
Antonio C. L. Nóbrega

1 November 2022 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
TJThomas J. Jurrissen
Thomas J. Jurrissen
FRFrancisco I. Ramirez-Perez
Francisco I. Ramirez-Perez
FCFrancisco J. Cabral-Amador
Francisco J. Cabral-Amador
Rogerio SoaresRogerio Soares
Rogerio Soares
RPRyan J. Pettit-Mee
Ryan J. Pettit-Mee
JPJaume Padilla
Jaume Padilla
Adropin is a peptide largely secreted by the liver and known to regulate energy homeostasis; however, it also exerts cardiovascular effects. Herein, we tested the hypothesis that low circulating levels of adropin in obesity and type 2 diabetes (T2D) contribute to arterial stiffening. In support of this hypothesis, we report that obesity and T2D are associated with reduced levels of adropin (in liver and plasma) and increased arterial stiffness in mice and humans. Establishing causation, we show that mesenteric arteries from adropin knockout mice are also stiffer, relative to arteries from wild-type counterparts, thus recapitulating the stiffening phenotype observed in T2D db/db mice. Given the above, we performed a set of follow-up experiments, in which we found that 1) exposure of endothelial cells or isolated mesenteric arteries from db/db mice to adropin reduces filamentous actin (F-actin) stress fibers and stiffness, 2) adropin-induced reduction of F-actin and stiffness in endothelial cells and db/db mesenteric arteries is abrogated by inhibition of nitric oxide (NO) synthase, and 3) stimulation of smooth muscle cells or db/db mesenteric arteries with a NO mimetic reduces stiffness. Lastly, we demonstrated that in vivo treatment of db/db mice with adropin for 4 wk reduces stiffness in mesenteric arteries. Collectively, these findings indicate that adropin can regulate arterial stiffness, likely via endothelium-derived NO, and thus support the notion that “hypoadropinemia” should be considered as a putative target for the prevention and treatment of arterial stiffening in obesity and T2D. NEW & NOTEWORTHY Arterial stiffening, a characteristic feature of obesity and type 2 diabetes (T2D), contributes to the development and progression of cardiovascular diseases. Herein we establish that adropin is decreased in obese and T2D models and furthermore provide evidence that reduced adropin may directly contribute to arterial stiffening. Collectively, findings from this work support the notion that “hypoadropinemia” should be considered as a putative target for the prevention and treatment of arterial stiffening in obesity and T2D.

1 April 2014 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
PDF file
ASAllan R. K. Sales
Allan R. K. Sales
IFIgor A. Fernandes
Igor A. Fernandes
NRNatália G. Rocha
Natália G. Rocha
LCLucas S. Costa
Lucas S. Costa
HRHelena N. M. Rocha
Helena N. M. Rocha
ANAntonio C. L. Nóbrega
Antonio C. L. Nóbrega
Mental stress induces transient endothelial dysfunction, which is an important finding for subjects at cardiometabolic risk. Thus, we tested whether aerobic exercise prevents this dysfunction among subjects with metabolic syndrome (MetS) and whether an increase in shear rate during exercise plays a role in this phenomenon. Subjects with MetS participated in two protocols. In protocol 1 ( n = 16), endothelial function was assessed using brachial artery flow-mediated dilation (FMD). Subjects then underwent a mental stress test followed by either 40 min of leg cycling or rest across two randomized sessions. FMD was assessed again at 30 and 60 min after exercise or rest, with a second mental stress test in between. Mental stress reduced FMD at 30 and 60 min after the rest session (baseline: 7.7 ± 0.4%, 30 min: 5.4 ± 0.5%, and 60 min: 3.9 ± 0.5%, P < 0.05 vs. baseline), whereas exercise prevented this reduction (baseline: 7.5 ± 0.4%, 30 min: 7.2 ± 0.7%, and 60 min: 8.7 ± 0.8%, P > 0.05 vs. baseline). Protocol 2 ( n = 5) was similar to protocol 1 except that the first period of mental stress was followed by either exercise in which the brachial artery shear rate was attenuated via forearm cuff inflation or exercise without a cuff. Noncuffed exercise prevented the reduction in FMD (baseline: 7.5 ± 0.7%, 30 min: 7.0 ± 0.7%, and 60 min: 8.7 ± 0.8%, P > 0.05 vs. baseline), whereas cuffed exercise failed to prevent this reduction (baseline: 7.5 ± 0.6%, 30 min: 5.4 ± 0.8%, and 60 min: 4.1 ± 0.9%, P < 0.05 vs. baseline). In conclusion, exercise prevented mental stress-induced endothelial dysfunction among subjects with MetS, and an increase in shear rate during exercise mediated this effect.

31 July 2021 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
IFIgor A. Fernandes
Igor A. Fernandes
JMJoão D. Mattos
João D. Mattos
MCMonique O. Campos
Monique O. Campos
MRMarcos P. Rocha
Marcos P. Rocha
DMDaniel E. Mansur
Daniel E. Mansur
ANAntonio C.L. Nóbrega
Antonio C.L. Nóbrega